Frontlight ResearchEarly access
Metastatic breast cancer trials, also abroad
609 open Metastatic breast cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| China | 224 |
| United States | 222 |
| France | 82 |
| Spain | 73 |
| Italy | 70 |
| All other countries |
The same trial often runs in several countries
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer has 4 sites in Austria and runs in 29 countries. If a site near you is full, another one may still take people.
See Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer in all 29 countries